Pricing Log in Create free account

Nuvation Bio Inc. (NUVB) vs Trevi Therapeutics, Inc. (TRVI)

Nuvation Bio Inc. and Trevi Therapeutics, Inc. are both Biotechnology companies. Nuvation Bio Inc. and Trevi Therapeutics, Inc. are of similar size ($1.7B and $1.7B). Trevi Therapeutics, Inc. has the higher net margin (0.00% vs −88.2%) and the lower return on invested capital (−1,412.1% vs 0.00%). Across the 14 metrics below, Trevi Therapeutics, Inc. leads on 10 and Nuvation Bio Inc. on 4.

Valuation

Metric NUVB TRVI Biotechnology median
P/E n/m n/m 8.50
P/S 9.13 n/m 9.71
P/B 6.11 5.78 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 6.71 n/m 9.21
Earnings yield (9.76%) (2.86%) (33.15%)
Free cash flow yield (7.79%) (2.84%) (25.50%)

Profitability

Metric NUVB TRVI Biotechnology median
Gross margin 88.18% 0.00% 65.16%
Operating margin (81.00%) 0.00% 0.00%
Net margin (88.19%) 0.00% 0.00%
Free cash flow margin (71.17%) 0.00% 0.00%
Return on equity (47.81%) (19.66%) (56.36%)
Return on assets (21.53%) (18.97%) (48.04%)
Return on invested capital 0.00% (1,412.11%) 0.00%

Growth

Metric NUVB TRVI Biotechnology median
Revenue growth (TTM) 1,083.56% — 6.02%
EPS growth (last fiscal year) 71.56% 31.91% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NUVB TRVI Biotechnology median
Debt to equity 0.98 0.00 0.00
Current ratio 8.37 37.28 4.72
Net debt to EBITDA 2.26 3.83 0.96

Dividend

Metric NUVB TRVI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NUVB TRVI Biotechnology median
Market cap 1.67b 1.73b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack